Remote ischemic preconditioning in open heart surgery

Remote ischemic preconditioning during single valve replacement in open heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201604001494317

Enrollment

Registered

2016-02-27

Start date

2011-02-07

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Surgery

Interventions

Group RIPC

Group C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Elective single valve replacement (Mitral or aortic)

Exclusion criteria

Exclusion criteria: Patients with airway and/or parenchymal lung disease. pulmonary hypertension more than 100 mmHg Immunodeficiency. hematological disorders. hepatic or renal impairment pregnancy morbid obesity diabetic. patients with myocardial ischemia or infarction. patients with peripheral vascular disease. patients receiving drugs that interfere with the mechanism of RIPC i.e. sulfonylureas, nicorandil or propofol.

Design outcomes

Primary

Measure	Time frame
Troponin I level	—

Secondary

Measure	Time frame
Duration of I.C.U. stay;Ventilation time ;Dose of inotropic support requirements	—

Countries

Egypt

Contacts

Public ContactSaad Saad

Professor

saadibrahim_7@yahoo.com+201223142889

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026